Eli Lilly and Company
LLYNYSEHealthcare● Active
$1,131.42
+$6.15(+0.55%)
Market Cap$1.07T
P/E Ratio—
52W High$1166.29
52W Low$623.78
Eli Lilly and Company (LLY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LLY · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $65.18B | $45.04B | $34.12B | $28.54B | $28.32B |
| Cost of Revenue | $10.56B | $8.42B | $7.08B | $6.63B | $7.31B |
| Gross Profit | $54.62B | $36.62B | $27.04B | $21.91B | $21.01B |
| Gross Margin %(computed) | 83.79% | 81.31% | 79.25% | 76.77% | 74.18% |
| Operating Expenses | |||||
| R&D Expenses | $13.34B | $10.99B | $9.31B | $7.19B | $6.93B |
| G&A Expenses | $11.09B | $8.13B | $6.94B | $6.07B | $6.14B |
| Total Operating Expenses | $24.92B | $19.12B | $16.25B | $13.26B | $13.07B |
| Operating Income | $29.70B | $17.50B | $10.79B | $8.65B | $7.93B |
| Operating Margin %(computed) | 45.56% | 38.86% | 31.61% | 30.32% | 28.01% |
| Interest Income | $0.15B | $0.18B | $0.17B | $0.06B | $0.03B |
| Interest Expense | $0.80B | $0.78B | $0.49B | $0.33B | $0.34B |
| Income Before Tax | $25.73B | $12.68B | $6.55B | $6.81B | $6.16B |
| Income Tax Expense | $5.09B | $2.09B | $1.31B | $0.56B | $0.57B |
| Net Income | $20.64B | $10.59B | $5.24B | $6.24B | $5.58B |
| Net Margin %(computed) | 31.66% | 23.51% | 15.36% | 21.88% | 19.71% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $23.00 | $11.76 | $5.83 | $6.57 | $5.85 |
| Wtd Avg Shares | 0.90B | 0.90B | 0.90B | 0.95B | 0.95B |
| EBITDA | $27.94B | $15.23B | $8.57B | $8.66B | $8.04B |
| EBITDA Margin %(computed) | 42.86% | 33.81% | 25.11% | 30.34% | 28.40% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Eli Lilly and Company data
About Eli Lilly and Company (LLY) Income Statement
Eli Lilly and Company (LLY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, LLY reported revenue of $65.18B, gross profit of $54.62B (gross margin 83.79%), and net income of $20.64B — a net profit margin of 31.66%.
Frequently asked questions
LLY · 4 questionsEli Lilly and Company (LLY) reported revenue of $65.18B for 2025, up 44.7% year-over-year.
LLY revenueLLY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08